OTX-202 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

11,626 results for “OTX-202”

Trials

View all 4090 →

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

850 participants · First posted Apr 7, 2026

OTX-14-002: Device Exposure Registry

First posted Dec 5, 2014

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

19 participants · First posted Apr 24, 2020

Drugs

View all 3974 →

Investigational

OTX-2002

OTX-2101

OTX-BDI

Organizations

View all 24 →

Ocular Therapeutix

United States

University of Sherbrooke

Canada

Gateway Biotechnology, Inc.

United States

News

View all 3538 →

Mobile App OTX-202 Reduces Suicide Attempts by 58% in High-Risk Psychiatric Patients

Ocular Therapeutix Advances OTX-TKI Phase 3 Trials for Wet AMD with Novel 9-Month Sustained Release Platform

Phase 1 HELIOS Trial Shows Promise for OTX-TKI in Diabetic Retinopathy Treatment

Page 1 of 1163